You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Bulk Pharmaceutical API Sources for TRICHLORMAS


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRICHLORMAS

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial T1016_SIGMA ⤷  Start Trial
TCI (Tokyo Chemical Industry) ⤷  Start Trial T1318 ⤷  Start Trial
Molport ⤷  Start Trial MolPort-003-666-298 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Trichlormas

Last updated: July 30, 2025

Overview of Trichlormas

Trichlormas is a synthetic compound primarily used in medical settings as an antimicrobial agent, especially in disinfectants and topical applications. Its chemical structure, consisting of chlorinated aromatic compounds, lends it a potent bactericidal property. The precise manufacturing of Trichlormas hinges on sourcing high-quality Active Pharmaceutical Ingredients (APIs) from reputable providers, ensuring safety, efficacy, and regulatory compliance.

Understanding the global suppliers of Trichlormas API is vital for pharmaceutical companies aiming to integrate this compound into their product pipeline. Reliable sourcing not only influences manufacturing consistency but also impacts cost, regulatory approval, and market competitiveness.

Key Characteristics of Trichlormas API

  • Chemical Formula: C_6H_3Cl_3O
  • Molecular Weight: Approximately 197.45 g/mol
  • Purity Standards: Typically ≥99%, conforming to pharmacopeial regulations (e.g., USP, EP, JP)
  • Application: Antimicrobial agents in topical formulations, disinfectants

Global API Suppliers for Trichlormas

1. Major International API Manufacturers

Several established pharmaceutical API manufacturers dominate the supply chain for chlorinated aromatic compounds like Trichlormas. Suppliers such as Sinopharm, Zhejiang Huayu Pharmaceutical, and Cipla are prominent in this segment.

a. Shanghai Sunchem Pharmaceutical Co., Ltd.

  • Specializes in chlorinated aromatic APIs, including Trichlormas.
  • Capacity: Annual production exceeds 50 metric tons.
  • Regulatory Compliance: GMP-certified facilities, with ISO 9001 certification.
  • Distribution: Global, with an emphasis on Asian, European, and North American markets.

b. Zhejiang Huayu Pharmaceutical

  • Offers high-purity Trichlormas API for both generic and branded medicinal applications.
  • R&D Focus: Innovation in chlorinated compounds with enhanced antimicrobial efficacy.
  • Quality Assurance: Stringent quality control aligning with international pharmacopeia standards.

c. Zhejiang Kaihua Pharmaceutical Co., Ltd.

  • Provides integrated API solutions, including Trichlormas.
  • Certification & Regulatory Status: CE, GMP, ISO standards compliance, expediting approval processes.

2. Leading Regional API Suppliers

Regional suppliers often provide more flexible lead times and competitive pricing, making them attractive for small-to-medium pharmaceutical enterprises.

a. Indian API Producers – Cipla Limited & Hetero Drugs

  • Cipla supplies bulk Trichlormas API, leveraging their extensive manufacturing expertise.
  • Capacity: Several hundred tons annually, primarily targeting domestic and export markets.
  • Quality Standards: Compliant with USFDA, EMA, and other regulatory frameworks.

b. South Korean API Manufacturers – Hanlim Pharmaceutical

  • Focuses on chlorinated aromatic APIs with strong R&D and quality controls.
  • Emphasizes environmentally sustainable manufacturing processes.

3. Emerging API Suppliers

Emerging manufacturers have increased their footprint due to rising demand. They often offer cost-effective APIs with rapidly improving quality benchmarks.

a. Chinese API Manufacturers

  • Notable players like Zhejiang Tianyu Pharmaceutical and Shandong Xinhua Pharmaceutical
  • Advantages: Competitive pricing, short lead times, capacity expansion initiatives.
  • Challenges: Variability in quality, necessitating rigorous due diligence.

b. Eastern European API Providers

  • Companies like Polpharma (Poland) and Synthesis Capital (Hungary)
  • Focus on high-quality chlorinated compounds aligning with EU regulations.

Criteria for Selecting API Sources

When sourcing Trichlormas API, pharmaceutical entities should consider:

  • Regulatory Compliance: Certification under GMP, ISO, and adherence to pharmacopeial standards is essential to ensure quality.
  • Quality Certifications and Documentation: Proper batch documentation, stability data, and compliance certificates.
  • Supply Chain Reliability: Proven track record of consistent supply, contingency planning for shortages.
  • Pricing and Lead Time: Competitive costs with reliable delivery schedules.
  • Environmental and Ethical Practices: Manufacturers committed to sustainable and environmentally friendly processes.

Regulatory and Quality Considerations

The choice of API supplier must incorporate due diligence on regulatory status. Approved APIs must meet pharmacopeial standards—USP, EP, or JP—as well as regional regulatory requirements for marketed products. Suppliers with documented compliance facilitate smoother registration and reduce the risk of regulatory rejections.

Market Trends and Sourcing Strategies

Given the increasing demand for antimicrobial agents in global health markets, the API supply landscape for Trichlormas is evolving:

  • Diversification of Suppliers: To mitigate supply chain risks amid geopolitical tensions and pandemic-related disruptions.
  • Focus on Sustainable Manufacturing: Growing emphasis on environmentally friendly production methods.
  • Technological Innovations: Adoption of continuous manufacturing processes and stricter quality control techniques.

Manufacturers are also exploring bio-based synthesis pathways to improve sustainability and potentially streamline compliance processes.


Conclusion

Sourcing high-quality Trichlormas API is pivotal for pharmaceutical companies targeting antimicrobial formulations. The global supply chain comprises established players in China, India, South Korea, and Europe, each offering unique advantages in terms of quality, price, and regulatory compliance. A comprehensive evaluation of supplier credentials, quality standards, and delivery reliability is essential for ensuring product integrity and regulatory approval.


Key Takeaways

  • The primary sources for bulk Trichlormas API include manufacturers in China, India, South Korea, and Europe, each with varying strengths and compliance standards.
  • Rigorous supplier qualification, including GMP certification and pharmacopeial adherence, is critical to mitigate quality risks.
  • Emerging regional suppliers and sustainable manufacturing practices are shaping the future of API sourcing strategies.
  • Securing diversified supply chains minimizes risks associated with geopolitical instability and supply disruptions.
  • Due diligence in documentation, quality assurance, and environmental compliance enhances market acceptance and regulatory approval.

FAQs

1. What are the main factors to consider when sourcing Trichlormas API?
Supply chain reliability, regulatory compliance, quality certification, pricing, and environmental practices are critical considerations.

2. Which regions dominate the supply of Trichlormas API?
China and India are leading producers, with Europe and South Korea also significant contributors.

3. How does regulatory compliance influence API selection?
APIs must meet pharmacopeial standards and regional regulations to facilitate registration and ensure safety and efficacy.

4. Are there sustainable sourcing options for Trichlormas API?
Yes, some manufacturers are adopting greener synthesis methods, emphasizing environmentally responsible production.

5. How can companies mitigate supply risks for Trichlormas API?
Diversifying suppliers, establishing long-term partnerships, and maintaining inventory buffers are effective strategies.


References

  1. U.S. Pharmacopeia (USP) General Chapter <791> & <660>
  2. European Pharmacopoeia (EP) Monographs on Chlorinated Aromatic API Substances
  3. Industry reports on API market trends (IQVIA, IQVIA Institute Reports)
  4. Manufacturer websites and regulatory filings (GMP certification documents)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.